At the JPMorgan Healthcare Conference in San Francisco, drugmakers signalled obesity drugs going mainstream, shifting from ...
Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...
The Gulf Specimen Marine Lab will have to take down its sign and is urging for an ordinance change to help them put up a new ...
Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
Dealbreaker on MSN
Nvidia deepens push into drug discovery via new partnerships with Lilly, Thermo Fisher & more
On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded ...
Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...
The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...
The New York-based company, previously known as VantAI and incubated at Roivant before a spinoff, is working in a ...
SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...
Leading tech giants Apple and Google are seeing a decline in the innovations they are making, the latest data suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results